We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Otsuka Pays $4 Million for Abilify Off-Label Marketing
Otsuka Pays $4 Million for Abilify Off-Label Marketing
January 14, 2009
Otsuka Pharmaceutical paid $4 million to resolve allegations that it marketed antipsychotic drug Abilify for off-label uses, according to the Justice Department.